ketamineTREATMENT FLORIDA
What the research shows

The evidence behind ketamine therapy

Ketamine is one of the most actively studied treatments in modern psychiatry. Here is a plain-language look at what the science supports — and, just as honestly, what remains an open question.

  • Peer-reviewed
  • Plain language
  • Honestly framed
The overview

Two decades of research point in a consistent direction: for some people with treatment-resistant depression and related conditions, supervised ketamine can produce meaningful, sometimes rapid improvement where other treatments have stalled. It is not a cure, not right for everyone, and best understood as a tool used within professional care.

The science, over time

Two decades of evidence, one clear direction

  1. 2000

    The first controlled signal

    An early randomized study reports rapid antidepressant effects from a single ketamine infusion — results that reopened serious research into a decades-old anesthetic.

  2. 2006

    Replication at the NIH

    A landmark National Institute of Mental Health trial replicates rapid improvement in treatment-resistant depression, often within hours — galvanizing the field.

  3. 2019

    FDA approval of esketamine

    The FDA approves Spravato® (esketamine) nasal spray for treatment-resistant depression in adults — the first genuinely new mechanism approved for depression in decades.

  4. 2020

    Expanded indication

    Esketamine gains an additional FDA indication for depressive symptoms in adults with major depressive disorder who have acute suicidal ideation or behavior.

  5. Today

    Evidence keeps building

    Research continues into anxiety, PTSD, OCD, bipolar depression, and chronic pain, refining who benefits most, optimal dosing, and how integration sustains results.

What the evidence does — and doesn't — say
  • Does: support rapid, meaningful relief for many with treatment-resistant depression.
  • Does: show a distinct mechanism — promoting neuroplasticity — unlike traditional antidepressants.
  • Doesn't: guarantee a response; a minority of people see little benefit.
  • Doesn't: replace ongoing care; durability depends on integration and follow-up.
  • Still studying: optimal dosing, long-term maintenance, and its role in anxiety, PTSD, and pain.
CONFIDENTIAL SUPPORT / 24-7

Have questions about the research?

We are happy to talk through what the evidence means for your situation — clearly, and without overselling it.